Key facts
- · Type: Amendment first sale 2025-10-31 · Amount sold: $1.97M · Total offering: $20M · SEC filing
- · Type: New offering first sale 2025-10-31 · Amount sold: $1.97M · Total offering: $20M · SEC filing
- · Type: New offering first sale 2023-09-25 · Amount sold: $1.43M · Total offering: $8M · SEC filing
Is Gut-Brain-Axis Therapeutics Inc. a real, registered company?
Gut-Brain-Axis Therapeutics Inc. is a registered filer with the SEC (CIK 1996678) and has filed since 2023-10-10. 3 filings are on record, the latest on 2026-10-27.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Who runs Gut-Brain-Axis Therapeutics Inc.?
Gut-Brain-Axis Therapeutics Inc.'s filings name James Adams, Michael Sadowsky, Alexander Khoruts and 3 more as its officers, directors or promoters.
How much has Gut-Brain-Axis Therapeutics Inc. raised?
Its new offerings report $3.39M sold across 2 offerings, as its own filings state.
Run the free check on Gut-Brain-Axis Therapeutics Inc. →
TEMPE, ARIZONA
2022
Biotechnology
3
$3.39M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-10-27 | Amendment first sale 2025-10-31 | $1.97M | $20M | details · SEC filing |
| 2025-11-06 | New offering first sale 2025-10-31 | $1.97M | $20M | details · SEC filing |
| 2023-10-10 | New offering first sale 2023-09-25 | $1.43M | $8M | SEC filing |
Want the whole picture on Gut-Brain-Axis Therapeutics Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Gut-Brain-Axis Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Gut-Brain-Axis Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Gut-Brain-Axis Therapeutics Inc.'s own filings with the SEC. The people those filings name are on the team page.